Image
Image
Image 11
Image 11
Patient A
Patient A
Patient A
Patient A
Patient B
Patient B
Patient C
Patient C
Patient C
Patient C
Patient D
Patient D
Patient D
Patient D
Patient E
Patient E
Patient E
Patient E
Posterior fossa ependymomas are now classified by DNA-methylation profiling into groups A (poor prognosis, primarily infants/young children) and B (good prognosis, primarily adolescents/adults); H3K27me3 immunohistochemistry (negative in group A, positive in group B) is a useful surrogate when molecular profiling unavailable
The plastic or toothpaste-like appearance with extension through foramina of Luschka and Magendie is a hallmark feature distinguishing ependymomas from other fourth-ventricular tumors
Heterogeneous signal and enhancement on MRI reflects the typical composition of ependymomas with necrosis, calcification, cystic change, and hemorrhage
Prognosis is relatively poor due to surgically challenging fourth-ventricular location; complete resection is difficult, and poor prognostic factors include grade 3 histology and incomplete resection
CSF seeding should be assessed despite being uncommon compared to medulloblastomas; the entire neuraxis should be carefully examined
Extraneural metastases are rare but can occur to lymph nodes, mediastinum, lungs, pleura, liver, bone, and retroperitoneum
Describe the characteristic location (fourth ventricle, arising from lateral recess or midline floor), plastic extension through the foramina of Luschka and Magendie, degree of hydrocephalus, and the heterogeneous nature (solid, cystic, calcification, hemorrhage) on both CT and MRI; note molecular subgroup if available (PFA vs. PFB) as this significantly impacts prognosis.